NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 289 filers reported holding NATERA INC in Q3 2022. The put-call ratio across all filers is 1.19 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,387,105 | -10.6% | 31,347 | -1.7% | 0.00% | 0.0% |
| Q2 2023 | $1,551,086 | +625.8% | 31,876 | +499.2% | 0.00% | – |
| Q4 2022 | $213,704 | -22.3% | 5,320 | -15.2% | 0.00% | – |
| Q3 2022 | $275,000 | -30.9% | 6,275 | +47.1% | 0.00% | – |
| Q4 2021 | $398,000 | -30.8% | 4,267 | -17.4% | 0.00% | -100.0% |
| Q3 2021 | $575,000 | -8.1% | 5,164 | -6.3% | 0.00% | 0.0% |
| Q2 2021 | $626,000 | -71.0% | 5,511 | -74.1% | 0.00% | -50.0% |
| Q1 2021 | $2,159,000 | +1.3% | 21,261 | -0.7% | 0.00% | 0.0% |
| Q4 2020 | $2,131,000 | +42.7% | 21,417 | +3.6% | 0.00% | 0.0% |
| Q3 2020 | $1,493,000 | +246.4% | 20,668 | +139.2% | 0.00% | +100.0% |
| Q2 2020 | $431,000 | +55.6% | 8,640 | +5.1% | 0.00% | – |
| Q4 2019 | $277,000 | -36.5% | 8,218 | -48.0% | 0.00% | -100.0% |
| Q2 2019 | $436,000 | – | 15,815 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 881,436 | $48,937,327 | 32.36% |
| Kynam Capital Management, LP | 2,918,237 | $162,020,518 | 20.92% |
| Sofinnova Investments, Inc. | 3,100,560 | $172,143,091 | 11.01% |
| Eversept Partners, LP | 2,819,770 | $156,553,630 | 10.92% |
| Eagle Health Investments LP | 784,894 | $43,577,315 | 8.48% |
| Lagoda Investment Management, L.P. | 162,625 | $9,028,940 | 6.42% |
| BEACONLIGHT CAPITAL, LLC | 204,567 | $11,357,560 | 6.00% |
| Bain Capital Life Sciences Investors, LLC | 700,197 | $38,875 | 4.86% |
| PERKINS CAPITAL MANAGEMENT INC | 62,700 | $3,481 | 3.28% |
| RTW INVESTMENTS, LP | 2,611,783 | $145,006,192 | 3.02% |